AstraZeneca

In News

AstraZeneca announces major financial investment to bring medical breakthroughs to patients' bedsides - WMAR 2 News Baltimore

WMAR 2 News Baltimore - Jun 22, 2026

[BIO USA 2026] AstraZeneca expands hunt for external innovation beyond single-asset licensing - koreabiomed.com

koreabiomed.com - Jun 23, 2026

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio - AstraZeneca

AstraZeneca - Jun 08, 2026

AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback - Yahoo Finance

Yahoo Finance - Jun 19, 2026

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial - Reuters

Reuters - Jun 08, 2026

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success - CNBC

CNBC - Jun 05, 2026

AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials - statnews.com

statnews.com - Jun 08, 2026

AstraZeneca Eyes India Launch for Oral GLP-1 Drug - NAVLIN DAILY

NAVLIN DAILY - Jun 22, 2026

AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders - Fierce Biotech

Fierce Biotech - Jun 05, 2026

AstraZeneca chief warns group could withhold new drugs in Europe - Financial Times

Financial Times - Jun 05, 2026

COPD Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Amgen, Synairgen, AstraZeneca, Sanofi, Organicell Regenerative Medicine - Barchart.com

Barchart.com - Jun 22, 2026

AstraZeneca reprimanded over LinkedIn likes once again - Fierce Pharma

Fierce Pharma - Jun 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment